12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Aclarion (ACON) saw a 75.8% increase, while Longeveron (LGVN) rose by 43.07%. Passage Bio (PASG), Dare Bioscience (DARE), Eterna Therapeutics (ERNA), and Kintara Therapeutics (KTRA) also saw upward movements. Conversely, bluebird bio (BLUE), Jin Medical International (ZJYL), argenx (ARGX), Xilio Therapeutics (XLO), Ontrak (OTRK), and Panbela Therapeutics (PBLA) experienced declines, with bluebird bio dropping 45.3%.
December 20, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
argenx stock decreased by 23.94% to $344.25, with a market cap of $20.3 billion.
argenx's significant pre-market decline suggests a negative reaction to company-specific events or broader market trends, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
bluebird bio stock fell sharply by 45.3% to $1.33, with a market cap of $145.5 million.
The dramatic pre-market drop in bluebird bio's stock price likely reflects negative investor sentiment or adverse news, which could result in continued short-term downward pressure.
CONFIDENCE 80
IMPORTANCE 95
RELEVANCE 100
POSITIVE IMPACT
Aclarion shares rose sharply by 75.8% to $0.51, with a market cap of $4.8 million.
The significant pre-market rise in Aclarion's stock price suggests positive investor sentiment or reaction to company-specific news, which could lead to continued short-term upward momentum.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Longeveron stock increased by 43.07% to $2.79, with a market cap of $66.2 million.
The substantial pre-market increase for Longeveron indicates strong investor interest, potentially due to recent company developments, which may lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100